Why the 'try-everything tactic' is gaining momentum in cancer care
Discover the potential of personalized drug testing for cancer treatment, but with caveats. Find out how this
Stay updated with breaking news from Solid Tumors. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Discover the potential of personalized drug testing for cancer treatment, but with caveats. Find out how this
The Janssen pharmaceutical companies of Johnson & Johnson announce that they have applied to the European Medicines Agency for an extension of the indication for Rybrevant . The idea is to obtain...
Ritu Salani, MD, provides expert insights regarding HER2 testing in patients with gynecological cancers, emphasizing the need for standardization in testing practices and greater clarity surrounding the incidence of HER2 positivity across gynecological cancers.
Martin Dietrich, MD, PhD, and Ritu Salani, MD, share their outlook on the future roles of HER2-directed ADCs in gynecological cancers and other solid tumors, highlighting the necessity for additional research to provide further understanding in these areas.
The first set of guidelines for treating solid tumors in children, published by the National Comprehensive Cancer Network.